OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 109 filers reported holding OCULAR THERAPEUTIX INC in Q3 2020. The put-call ratio across all filers is 1.19 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,140 | -86.7% | 1,000 | -78.2% | 0.00% | – |
| Q2 2023 | $23,664 | -25.2% | 4,586 | -23.6% | 0.00% | -100.0% |
| Q1 2023 | $31,620 | +22.0% | 6,000 | -35.0% | 0.00% | – |
| Q4 2022 | $25,922 | +8.0% | 9,225 | +61.1% | 0.00% | – |
| Q3 2022 | $24,000 | +242.9% | 5,725 | +231.9% | 0.00% | – |
| Q2 2022 | $7,000 | -22.2% | 1,725 | 0.0% | 0.00% | – |
| Q1 2022 | $9,000 | -25.0% | 1,725 | 0.0% | 0.00% | – |
| Q4 2021 | $12,000 | -29.4% | 1,725 | 0.0% | 0.00% | – |
| Q3 2021 | $17,000 | -29.2% | 1,725 | 0.0% | 0.00% | – |
| Q2 2021 | $24,000 | -100.0% | 1,725 | -50.0% | 0.00% | – |
| Q1 2021 | $56,614,000 | +157161.1% | 3,450 | +100.0% | 0.00% | -100.0% |
| Q4 2020 | $36,000 | +260.0% | 1,725 | +25.5% | 0.00% | – |
| Q3 2020 | $10,000 | +25.0% | 1,375 | +37.5% | 0.00% | – |
| Q2 2020 | $8,000 | +100.0% | 1,000 | 0.0% | 0.00% | – |
| Q1 2020 | $4,000 | +33.3% | 1,000 | 0.0% | 0.00% | – |
| Q4 2019 | $3,000 | 0.0% | 1,000 | 0.0% | 0.00% | – |
| Q3 2019 | $3,000 | -25.0% | 1,000 | 0.0% | 0.00% | – |
| Q2 2019 | $4,000 | – | 1,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 6,122,089 | $32,263 | 100.00% |
| Opaleye Management Inc. | 6,105,900 | $32,178,093 | 9.64% |
| DELTEC ASSET MANAGEMENT LLC | 1,913,612 | $10,084,735 | 2.49% |
| Knoll Capital Management, LLC | 200,000 | $1,504,000 | 2.32% |
| Endurant Capital Management LP | 512,744 | $2,702,161 | 1.39% |
| Knoll Capital Management, LLC | 95,800 | $504,866 | 0.78% |
| Covestor Ltd | 60,008 | $316 | 0.28% |
| Ikarian Capital, LLC | 200,000 | $1,054,000 | 0.24% |
| EAM Investors, LLC | 224,211 | $1,181,592 | 0.23% |
| Nebula Research & Development LLC | 22,474 | $118,438 | 0.21% |